Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Arthroplasty ; 34(1): 123-125, 2019 01.
Article in English | MEDLINE | ID: mdl-30316624

ABSTRACT

BACKGROUND: Periprosthetic joint infection (PJI) remains a major clinical challenge. In this study, we evaluated the diagnostic performance of lipocalin-2 (LCN2), a well-characterized neutrophil protein, in synovial fluid to discriminate PJI and aseptic implant failure. METHODS: Synovial fluid from patients with acute or chronic PJI, aseptic failure, or controls was obtained during surgery. LCN2 was quantified using a modified enzyme immunoassay coupled with chemiluminescence (Architect Urine NGAL; Abbott Laboratories). RESULTS: Synovial fluid was collected from 72 patients: 22 (30.6%) proven infections, 22 (30.6%) aseptic implant failures, and 28 (38.8%) controls. Synovial fluid was obtained from the hip in 18 (25%) and knee in 54 (75%) cases. Among infections, there were 16 (22.2%) acute and 6 (8.3%) chronic PJIs. The median (interquartile range) LCN2 concentration in synovial fluid was 1536.5 ng/mL (261.8-12,923) in the infection group, 87.0 (54.8-135) in the aseptic group, and 55 (45-67.8) in the control group (P < .001). LCN2 discriminated nearly perfectly between controls and confirmed infection (area under the receiver operating characteristic 0.98, 95% confidence interval 0.95-1.00). The optimal cut-off value for maximal sensitivity (86.3%) and specificity (77.2%) to discriminate aseptic failure versus proven infection was 152 ng/mL, with an area under the receiver operating characteristic of 0.92 (95% confidence interval 0.84-0.99). CONCLUSION: LCN2 is a potential novel biomarker that may be helpful to inform surgical teams on the potential risk of PJI and optimize specific surgical interventions as it distinguishes between septic and aseptic failure of prosthesis with high sensitivity and specificity.


Subject(s)
Arthritis, Infectious/diagnosis , Hip Prosthesis/adverse effects , Knee Prosthesis/adverse effects , Lipocalin-2/analysis , Prosthesis-Related Infections/diagnosis , Aged , Arthritis, Infectious/microbiology , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Biomarkers/analysis , Case-Control Studies , Female , Humans , Knee Joint , Male , Middle Aged , Neutrophils , Prosthesis-Related Infections/microbiology , ROC Curve , Sensitivity and Specificity , Synovial Fluid/chemistry
2.
Front Microbiol ; 12: 630826, 2021.
Article in English | MEDLINE | ID: mdl-33597942

ABSTRACT

Background: KPC-producing Klebsiella pneumoniae (KPCKP) is a threat for patients admitted to healthcare institutions. Objectives: To assess the efficacy of several decolonization strategies for KPCKP rectal carriage. Methods: Observational study performed in a 750-bed university center from July to October 2018 on the efficacy of a 10-day non-absorbable oral antibiotic (NAA) regimen (colistin 10 mg/ml, amikacin 8 mg/ml, and nystatin 30 mg/ml, 10 ml/6 h) vs. the same regimen followed by a probiotic (Vivomixx®) for 20 days in adult patients with KPCKP rectal colonization acquired during an outbreak. Results: Seventy-three patients colonized by KPCKP were included, of which 21 (29%) did not receive any treatment and 52 (71.2%) received NAA either alone (n = 26, 35.6%) or followed by a probiotic (n = 26, 35.6%). Eradication was observed in 56 (76.7%) patients and the only variable significantly associated with it was not receiving systemic antibiotics after diagnosis of rectal carriage [22/24 (91.6%) vs. 34/49 (69.3%), p = 0.04]. Eradication in patients receiving NAA plus probiotic was numerically but not significantly higher than that of controls [23/26 (88.4%) vs. 15/21 (71.4%), p = 0.14] and of those receiving only NAA (OR = 3.4, 95% CI = 0.78-14.7, p = 0.09). Conclusion: In an outbreak setting, rectal carriage of KPCKP persisted after a mean of 36 days in about one quarter of patients. The only factor associated with eradication was not receiving systemic antibiotic after diagnosis. A 10-day course of NAA had no impact on eradication. Probiotics after NAA may increase the decolonization rate, hence deserving further study.

3.
PLoS One ; 14(8): e0220307, 2019.
Article in English | MEDLINE | ID: mdl-31390352

ABSTRACT

OBJECTIVES: Conventional microbiological procedures for the isolation of bacteria from biological fluids consist of culture on solid media and enrichment broth. However, these methods can delay the microbiological identification for up to 4 days. The aim of this study was to evaluate the analytical performance of Sysmex UF500i (Sysmex, Kobe, Japan) as a screening method for the detection of bacteria in different biological fluids in comparison with direct Gram staining and the conventional culture on solid media and enrichment broth. METHODS: A total of 479 biological fluid samples were included in the study (180 ascitic, 131 amniotic, 56 synovial, 40 cerebrospinal, 36 pleural, 24 peritoneal, 9 bile and 3 pericardial fluids). All samples were processed by conventional culture methods and analyzed by flow cytometry. Direct Gram staining was performed in 339 samples. The amount of growth on culture was recorded for positive samples. RESULTS: Bacterial and white blood cell count by flow cytometry was significantly higher among culture positive samples and samples with a positive direct Gram stain compared to culture negative samples. Bacterial count directly correlated with the amount of growth on culture (Kruskall-Wallis H χ2(3) = 11.577, p = 0.009). The best specificity (95%) for bacterial count to predict culture positivity was achieved applying a cut-off value of 240 bacteria/µL. CONCLUSIONS: Bacterial and white blood cell counts obtained with flow cytometry correlate with culture results in biological fluids. Bacterial count can be used as a complementary method along with the direct Gram stain to promptly detect positive samples and perform other diagnostic techniques in order to accelerate the bacterial detection and identification.


Subject(s)
Bacteria/isolation & purification , Body Fluids/microbiology , Flow Cytometry , Adult , Aged , Female , Humans , Male , Middle Aged , ROC Curve
4.
Rev Iberoam Micol ; 36(2): 90-92, 2019.
Article in English | MEDLINE | ID: mdl-30853370

ABSTRACT

BACKGROUND: Phaeoacremonium parasiticum is considered a rare infectious agent that is part of a heterogeneous group of fungi causing phaeohyphomycosis. This organism is capable of producing subcutaneous infections, eumycetomas, osteomyelitis, arthritis, myositis and also disseminated diseases, such as fungemia and endocarditis. CASE REPORT: We describe a case of cutaneous infection by P. parasiticum in a kidney transplant patient. The identification of this microorganism was performed by microbiological and histopathological studies and confirmed with the sequence of the gene encoding ß-tubulin and a real time panfungal PCR targeting 18S ribosomal RNA gene. The microorganism was correctly identified by phenotypic and molecular methods. The patient was treated with oral antifungal therapy and a debulking surgery and evolved without any complication. CONCLUSIONS: The diagnosis of this infection is difficult and usually affects kidney transplant patients, but the reasons of this association are still unknown.


Subject(s)
Ascomycota/isolation & purification , Dermatomycoses/microbiology , Kidney , Phaeohyphomycosis/microbiology , Transplant Recipients , Ascomycota/genetics , Dermatomycoses/therapy , Humans , Immunocompromised Host , Male , Middle Aged , Phaeohyphomycosis/therapy , Phenotype , RNA, Ribosomal, 18S/genetics , Tubulin/genetics
5.
Rev. iberoam. micol ; 36(2): 90-92, abr.-jun. 2019. ilus
Article in English | IBECS (Spain) | ID: ibc-185483

ABSTRACT

Background: Phaeoacremonium parasiticum is considered a rare infectious agent that is part of a heterogeneous group of fungi causing phaeohyphomycosis. This organism is capable of producing subcutaneous infections, eumycetomas, osteomyelitis, arthritis, myositis and also disseminated diseases, such as fungemia and endocarditis. Case report: We describe a case of cutaneous infection by P. parasiticum in a kidney transplant patient. The identification of this microorganism was performed by microbiological and histopathological studies and confirmed with the sequence of the gene encoding β-tubulin and a real time panfungal PCR targeting 18S ribosomal RNA gene. The microorganism was correctly identified by phenotypic and molecular methods. The patient was treated with oral antifungal therapy and a debulking surgery and evolved without any complication. Conclusions: The diagnosis of this infection is difficult and usually affects kidney transplant patients, but the reasons of this association are still unknown


Antecedentes: Phaeoacremonium parasiticum es considerado un agente infeccioso poco común que forma parte de un grupo heterogéneo de hongos causantes de feohifomicosis. Este microorganismo es capaz de producir infección cutánea, eumicetoma, osteomielitis, artritis, miositis e incluso enfermedad diseminada como fungemia y endocarditis. Caso clínico: Se describe un caso de infección cutánea por P. parasiticum en un paciente trasplantado renal. Para la identificación del microorganismo se realizaron pruebas microbiológicas e histopatológicas, y se confirmó la identificación con la secuenciación del gen de la β-tubulina y una PCR a tiempo real para la detección del gen 18S rRNA. El microorganismo fue identificado correctamente por métodos fenotípicos y moleculares. El paciente recibió tratamiento con antifúngicos orales y citorreducción quirúrgica, y evolucionó sin ninguna complicación. Conclusiones: El diagnóstico de esta infección es difícil y se presenta habitualmente en pacientes trasplantados renales. Sin embargo, la asociación de esta infección con este tipo de pacientes no ha sido aún explicada


Subject(s)
Humans , Male , Aged , Ascomycota/isolation & purification , Dermatomycoses/microbiology , Kidney , Phaeohyphomycosis/microbiology , Transplant Recipients , Ascomycota/genetics , Dermatomycoses/therapy , Immunocompromised Host , Phaeohyphomycosis/therapy , Phenotype , RNA, Ribosomal, 18S/genetics , Tubulin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL